AES (AES) Q3 2024 Earnings Call Transcript

AES reported Q3 adjusted EPS of $0.71 versus $0.60 a year ago and adjusted EBITDA with tax attributes of about $1.2 billion, while reaffirming 2024 guidance and saying it remains on track for the upper half of adjusted EPS and tax-attribute EBITDA ranges. Management also highlighted 9.1 GW of renewables PPAs signed or awarded since 2023, 2.8 GW commissioned year-to-date, $1.2 billion of U.S. utility investment, and more than $2.6 billion in asset sale proceeds signed or closed. Offsetting the positives, full-year adjusted EBITDA is now expected toward the low end of guidance due to extreme weather in Colombia and lower Energy Infrastructure margins.

Analysis

AES is shifting from a story of headline growth to a story of timing, mix, and optionality. The market should care less about the quarter's weather noise and more about the fact that the company is converting contracted backlog into a larger, higher-quality forward earnings base while simultaneously shrinking the amount of capital trapped in lower-return or higher-risk jurisdictions. That combination usually compresses the discount rate on the equity: less FX/sovereign/commodity exposure, more U.S. utility-like cash flow, and a clearer line of sight to dividend capacity.

The biggest second-order effect is that data-center demand is turning AES Ohio and Indiana from “regulated growth” into quasi-infrastructure platforms with embedded load growth optionality. That matters because each incremental MW signed likely pulls forward wires, generation, and rate-base investment, which should lift not just revenue but allowed earnings duration. The hidden winner is the domestic supply chain ecosystem around transformers, inverters, EPCs, and battery modules: AES is signaling enough visibility through 2026-27 to lock in procurement earlier, which should favor suppliers with domestic manufacturing footprints and squeeze less-prepared competitors on lead times and tariff resilience.

The main risk is not the weather shock itself; it is that investors extrapolate a cleaner 2025 reset into a permanently higher growth rate before the cash conversion proves out. If Colombia normalizes and U.S. renewables commissions on schedule, the stock can rerate quickly; if utility load growth slips or project economics get diluted by lower tax-credit monetization, the multiple likely stalls despite better optics. A subtle but important watch item is Moody's: if methodology changes recognize more of the amortizing project-finance debt and parent-level cash generation, AES could get a lower funding cost, which would compound the equity story over 6-12 months.

Consensus is probably underestimating how much of the apparent 'flat' renewables EBITDA is a portfolio rotation artifact rather than a deterioration in underlying project returns. That said, the burden of proof now shifts to 2025-26 execution, because the equity is increasingly being priced on forward monetization, rate-base expansion, and de-risked cash extraction rather than legacy asset churn. This is constructive, but it narrows the margin for operational misses.

Key Decisions for Investors

• Go long AES on pullbacks over the next 2-6 weeks; risk/reward improves if the market keeps discounting weather-driven noise while ignoring 2025 normalization and utility load optionality. Target a 6-12 month horizon.
• Add a relative-value long AES / short utility laggards with weaker data-center exposure and slower rate-base growth; the cleaner catalyst path should support multiple divergence over the next 1-2 quarters.
• For higher-conviction upside, buy AES Jan-2026 or Jan-2027 calls on any post-earnings weakness; the thesis is a delayed rerating as U.S. renewables, utility capex, and asset-sale credit benefits flow through.
• Stay alert for a Moody's methodology update within 1-3 months; if it is favorable, consider adding to AES and financing the trade by trimming lower-beta regulated names, since funding-cost relief could be a non-linear catalyst.
• Avoid chasing after sharp rallies until management gives the February 2025 update; execution risk is now concentrated in the next guidance reset, and the stock is vulnerable if the market front-runs 2026-27 inflection too aggressively.